Navigation Links
AMDL, Inc. Retains Strategic Growth International Inc. as its Global Investor Relations Advisor
Date:6/20/2008

NEW YORK, June 20 /PRNewswire-FirstCall/ -- AMDL, Inc. (Amex: ADL), announced today it has retained Strategic Growth International, Inc. ("SGI"), a global investor relations firm, to assist the Company in growing its financial market presence. SGI will assist the Company in establishing a stronger understanding of the investment opportunity AMDL represents while increasing the Company's awareness across global investment communities.

Gary Dreher, CEO of AMDL, commented, "As we continue building AMDL into a world-class pharmaceutical company we feel strong communications is imperative to our success. SGI has a strong reputation with an exceptional team and we're excited to have them as a partner to communicate our corporate story, the great progress we're making with new products and technologies in the U.S., China, and other global markets, and most important, how we intend to meet our stated financial targets of doubling annual sales consecutively over the next 3 years."

SGI Co-Founder Rich Cooper also commented saying, "We believe a strong investment story exists with AMDL and we're excited the company has chosen us to support their IR efforts. Through our combined efforts we will focus on achieving a fair and sustainable market valuation for AMDL while enhancing their reputation with investors, analysts, and the financial media."

Founded in 1989, SGI is headed by Richard E. Cooper and Stanley Altschuler, both long-time and highly-respected Wall Street veterans. Prior to his co-founding SGI, Mr. Cooper was a Managing Director at Salomon Brothers for five of his 14 years at the firm. Mr. Altschuler owned and managed a New York-based brokerage firm.

About AMDL

AMDL, Inc. is a global specialty pharmaceutical company. The Company is headquartered in Tustin, California with operations in Shenzhen, Jiangxi, and Jilin, China. Along with its subsidiary Jade Pharmaceutical Inc. (JPI), AMDL is devoted to the research, development, manufacture, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products currently in China. The company employs approximately 320 people in the U.S. and China. More information about AMDL and its products can be obtained at http://www.amdl.com.

Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to our ability to successfully complete Phase III clinical trials and secure regulatory approval of our current or future drug-delivery system and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.

AMDL Contact: Investor Relations Contact:

Kristine Szarkowitz Strategic Growth International, Inc.

Director-Investor Relations Richard E. Cooper - rcooper@sgi-ir.com

kszarkowitz@amdl.com Cass Almendral - cass@sgi-ir.com

(206) 310-5323 (212) 838-1444/ http://www.sgi-ir.com


'/>"/>
SOURCE AMDL, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. SPO Medical Retains American Capital Ventures for Investor Relations Services
2. Interleukin Genetics Retains Top Life Science Communications Firms
3. Dragon retains leading investor relations firm
4. NuRx Pharmaceuticals Retains Russo Partners for Investor Relations, Corporate Communications Counsel
5. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
6. China Pharma Holdings, Inc. Retains HC International, Inc. to Implement Investor Relations Program
7. Biomoda, Inc. Retains MicroCap Management, LLC as its Lead Corporate Communications and Broker Relations Firm.
8. ThromboGenics and BioInvent Announce a Strategic Alliance With Roche for TB-403, a Novel Anti-Cancer Antibody
9. Paul Capital Healthcare Leads Panel on Strategic Financing
10. AHIMA Reacts in Support of NAHITs New Strategic and Operating Framework
11. Official Signing Ceremony for WIBP Strategic Alliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/9/2017)... SAN DIEGO , Oct. 9, 2017 /PRNewswire/ ... a biological mechanism by which its ProCell stem ... of critical limb ischemia.  The Company, demonstrated that ... the amount of limbs saved as compared to ... of the molecule HGF resulted in reduction of ...
(Date:10/9/2017)... Arizona (PRWEB) , ... October 09, 2017 , ... ... Kindred, a four-tiered line of medical marijuana products targeting the needs of consumers ... and packaging of Kindred takes place in Phoenix, Arizona. , As operators of ...
(Date:10/7/2017)... ... October 06, 2017 , ... ... technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, featuring the first commercially ... cloud-based bioinformatics software to perform Hi-C metagenome deconvolution using their own facilities, ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... to expand at a CAGR of 25.76% during the ... is the primary factor for the growth of the ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem ... technology, application, and geography. The stem cell market of ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
(Date:3/27/2017)... N.Y. , March 27, 2017  Catholic ... Information and Management Systems Society (HIMSS) Analytics for ... EMR Adoption Model sm . In addition, CHS ... of U.S. hospitals using an electronic medical record ... for its high level of EMR usage in ...
Breaking Biology News(10 mins):